Literature DB >> 16316588

The role of inflammation as a pathogenic factor in the development of renal disease in diabetes.

Carmen Mora1, Juan F Navarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16316588     DOI： 10.1007/s11892-005-0044-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  30 in total

1.  Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells.

Authors:  J Pfeilschifter; W Pignat; K Vosbeck; F Märki
Journal:  Biochem Biophys Res Commun       Date:  1989-03-15       Impact factor: 3.575

2.  Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.

Authors:  Ashraf Aminorroaya; Mohsen Janghorbani; Hassan Rezvanian; Taghi Aminian; Manouchehr Gharavi; Massoud Amini
Journal:  Nephron Clin Pract       Date:  2005-01-19

3.  Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy.

Authors:  Darren J Kelly; Anna Chanty; Renae M Gow; Yuan Zhang; Richard E Gilbert
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

4.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

5.  Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.

Authors:  Fiona Y Chow; David J Nikolic-Paterson; Elyce Ozols; Robert C Atkins; Gregory H Tesch
Journal:  J Am Soc Nephrol       Date:  2005-04-27       Impact factor: 10.121

6.  Association between C-reactive protein and features of the metabolic syndrome: a population-based study.

Authors:  M Fröhlich; A Imhof; G Berg; W L Hutchinson; M B Pepys; H Boeing; R Muche; H Brenner; W Koenig
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

7.  Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats.

Authors:  Kambiz Kalantarinia; Alaa S Awad; Helmy M Siragy
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

8.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

9.  Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.

Authors:  Juan F Navarro; Carmen Mora; Mercedes Muros; Manuel Maca; Javier Garca
Journal:  Am J Kidney Dis       Date:  2003-08       Impact factor: 8.860

10.  Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.

Authors:  J Han; P Thompson; B Beutler
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307
View more
  13 in total

1.  Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.

Authors:  Sridevi Devaraj; Peter Tobias; Balakuntalam S Kasinath; Rajendra Ramsamooj; Alaa Afify; Ishwarlal Jialal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-26       Impact factor: 8.311

2.  Intensive insulin therapy reduces the urinary intercellular adhesion molecule-1 excretion in patients with Type 2 diabetes mellitus.

Authors:  Z Sun; S Ye; Y Qian; L Sui
Journal:  J Endocrinol Invest       Date:  2009-12       Impact factor: 4.256

3.  Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus.

Authors:  Qijin Zhu; Xiangming Qi; Yonggui Wu; Kun Wang
Journal:  Int Urol Nephrol       Date:  2016-06-24       Impact factor: 2.370

4.  Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.

Authors:  Yi-Hua Yang; Xiao-Jie He; Shen-Ren Chen; Ling Wang; En-Min Li; Li-Yan Xu
Journal:  Endocrine       Date:  2009-04-24       Impact factor: 3.633

5.  The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.

Authors:  Volha Ninichuk; Alexander G Khandoga; Stephan Segerer; Pius Loetscher; Achim Schlapbach; Laszlo Revesz; Roland Feifel; Andrej Khandoga; Fritz Krombach; Peter J Nelson; Detlef Schlöndorff; Hans-Joachim Anders
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

6.  Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy.

Authors:  Qingfeng Yin; Qianqian Zhai; Di Wang; Jie Hai; Meng Cao; Jianling Wang; Tao Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

7.  Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.

Authors:  Volha Ninichuk; Sebastian Clauss; Onkar Kulkarni; Holger Schmid; Stephan Segerer; Ewa Radomska; Dirk Eulberg; Klaus Buchner; Norma Selve; Sven Klussmann; Hans-Joachim Anders
Journal:  Am J Pathol       Date:  2008-02-07       Impact factor: 4.307

8.  Interleukin-10-1082A/G polymorphism and diabetic nephropathy: a meta-analysis.

Authors:  Xia Peng; Jiayun Xu; Pengpeng Wang; Jinjin Zhou; Hong Guo
Journal:  Med Sci Monit       Date:  2015-03-25

9.  The Influence of Corn Silk Polysaccharide on Signal Pathway of TGF-β1 in Type 2 Diabetic Mellitus Rat.

Authors:  Xianchun Wen; Liling Yue
Journal:  Open Biomed Eng J       Date:  2015-08-31

10.  Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice.

Authors:  Yong-Liang Yuan; Chang-Run Guo; Ling-Ling Cui; Shi-Xia Ruan; Chun-Feng Zhang; De Ji; Zhong-Lin Yang; Fei Li
Journal:  Drug Des Devel Ther       Date:  2015-11-27       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.